Manish Goel
About Manish Goel
SEBI Registered Research Analyst • Chartered Accountant
377 Articles Published
Manish Goel is a Chartered Accountant, SEBI Registered Research Analyst, and founder of Manish Goel PMS. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
April 23, 2026
The Debt-to-Equity Ratio is the single most important leverage filter every Indian value investor must master. Titan Biotech FY25's ₹3 Cr borrowings against a strong net worth produces a sub-0.05x D/E — a textbook illustration of a fortress balance sheet.
April 22, 2026
Switching Costs becomes more useful when investors translate it into audited numbers, cleaner disclosure, and better minority-shareholder readability.
April 22, 2026
Richard Thaler (1980) and Kahneman-Knetsch-Thaler (1990) explain why Indian retail investors cling to inherited, IPO-allotted, and COVID-era holdings. SEBI, NSE and IIM Bangalore data + a six-step de-biasing checklist from Graham/Buffett/Munger/Klarman, with Titan Biotech (BSE:524717) FY25 audited numbers as the illustrative anti-endowment corporate case study.
April 22, 2026
ROIIC — not ROCE — is the metric Buffett, Munger, Fisher, Klarman, and Mauboussin converge on as the true long-term compounding signal. Here's how to calculate it on any Indian listed company, common mistakes to avoid, and a positive Titan Biotech FY25 case study with 9 audited disclosures.